Neha Mehta-Shah, MD, Washington University in St Louis, St Louis, MO, discusses research into clonal evolution in patients with cutaneous T-cell lymphoma (CTCL), and the impact these findings could have on targeted therapy for these patients in the future. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
